Masayuki Hisada - Concepedia

Author

Masayuki Hisada

Tokyo Medical University

Also Known As

M Hisada, M. Hisada, Masayuki HISADA, Masayuki Hisada

Publications

813

Citations

H-Index

Concepts

All Affiliations

Tokyo Medical University Johns Hopkins University Johns Hopkins Medicine Tokyo Medical University Hospital Keio University

About

Masayuki Hisada is an author at Tokyo Medical University specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	214
2	Cell Biology	3	3	130
3	Pathology	2	2	65
4	Cellular Physiology	1	1	66
5	Immunology	1	1	66

Masayuki Hisada

Publications

746

Citations

H-Index

Page 1

	Year	Citations
Potent Antitumor Activity of Interleukin-27 Masayuki Hisada, Sadahiro Kamiya, Koji Fujita, Cancer Research	2004	243
Promotion of Expansion and Differentiation of Hematopoietic Stem Cells by Interleukin-27 into Myeloid Progenitors to Control Infection in Emergency Myelopoiesis Jun-ichi Furusawa, Izuru Mizoguchi, Yukino Chiba, PLoS Pathogens	2016	74
Interleukin-6 Is an Important Mediator for Mitochondrial DNA Repair After Alcoholic Liver Injury in Mice Xiuying Zhang, Shingo Tachibana, Hua Wang, Hepatology	2010	73
Complete laparoscopic resection of the rectum using natural orifice specimen extraction Masayuki Hisada World Journal of Gastroenterology	2014	73
Positive Modulation of IL-12 Signaling by Sphingosine Kinase 2 Associating with the IL-12 Receptor β1 Cytoplasmic Region Takayuki Yoshimoto, Masae Furuhata, Sadahiro Kamiya, The Journal of Immunology Positive ModulationImmune RegulationImmunologyJanus Kinase 2Sphingosine Kinase 2	2003	66
Efficacy and safety of neoadjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and levofolinate for T3 or T4 stage II/III rectal cancer: the FACT trial Junichi Koike, Kimihiko Funahashi, Kazuhiko Yoshimatsu, Cancer Chemotherapy and Pharmacology Fact TrialGastrointestinal OncologyMedicineSurgeryCancer Treatment	2017	50
Mobilization of Host Stem Cells Enables Long-Term Liver Transplant Acceptance in a Strongly Rejecting Rat Strain Combination Takehiro Okabayashi, Andrew Cameron, Masayuki Hisada, American Journal of Transplantation	2011	38
Etodolac, a selective cyclooxygenase-2 inhibitor, inhibits liver metastasis of colorectal cancer cells via the suppression of MMP-9 activity Tetsuo Ishizaki, Kenji Katsumata, Akihiko Tsuchida, International Journal of Molecular Medicine Tumor BiologyCox-2 MrnaCox-2 InhibitorSelective Cox-2 InhibitorChemoprevention Strategy	2006	34
Synergistic antitumor effect by coexpression of chemokine CCL21/SLC and costimulatory molecule LIGHT Masayuki Hisada, Takayuki Yoshimoto, Sadahiro Kamiya, Cancer Gene Therapy MedicineChemokine Ccl21/slcPharmacologySynergistic Antitumor EffectTumor Targeting	2004	33
Detection and evaluation of epithelial cells in the blood of colon cancer patients using RT-PCR Kenji Katsumata, Tetsuo Sumi, Yasuharu Mori, International Journal of Clinical Oncology Colon Cancer PatientsCancer DetectionMedicineEpithelial CellsColorectal Cancer	2006	31

Page 1